Cited by 353Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismDiet, Metabolism, and Disease

Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats

Open access
Fu, Wenjiang J., Haynes, Tony E., Kohli, Ripla, Hu, Jianbo, Shi, Wenjuan, Spencer, Thomas E., Carroll, Raymond J., Meininger, Cynthia J. +1 more·2005·The Journal of Nutrition

Abstract

This study was conducted to test the hypothesis that dietary supplementation of arginine, the physiologic precursor of nitric oxide (NO), reduces fat mass in the Zucker diabetic fatty (ZDF) rat, a genetically obese animal model of type-II diabetes mellitus. Male ZDF rats, 9 wk old, were pair-fed Purina 5008 diet and received drinking water containing arginine-HCl (1.51%) or alanine (2.55%, isonitrogenous control) for 10 wk. Serum concentrations of arginine and NO(x) (oxidation products of NO) were 261 and 70% higher, respectively, in arginine-supplemented rats than in control rats. The body weights of arginine-treated rats were 6, 10, and 16% lower at wk 4, 7, and 10 after the treatment initiation, respectively, compared with control rats. Arginine supplementation reduced the weight of abdominal (retroperitoneal) and epididymal adipose tissues (45 and 25%, respectively) as well as serum concentrations of glucose (25%), triglycerides (23%), FFA (27%), homocysteine (26%), dimethylarginines (18-21%), and leptin (32%). The arginine treatment enhanced NO production (71-85%), lipolysis (22-24%), and the oxidation of glucose (34-36%) and octanoate (40-43%) in abdominal and epididymal adipose tissues. Results of the microarray analysis indicated that arginine supplementation increased adipose tissue expression of key genes responsible for fatty acid and glucose oxidation: NO synthase-1 (145%), heme oxygenase-3 (789%), AMP-activated protein kinase (123%), and peroxisome proliferator-activated receptor gamma coactivator-1alpha (500%). The induction of these genes was verified by real-time RT-PCR analysis. In sum, arginine treatment may provide a potentially novel and useful means to enhance NO synthesis and reduce fat mass in obese subjects with type-II diabetes mellitus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jn/135.4.714

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dietary L-arginine supplementation in rats reduces fat mass, increases skeletal muscle and brown fat mass, and reduces serum concentrations of glucose, triglycerides, free fatty acids, homocysteine, dimethylarginines, and leptin.

    “In rats, not only has dietary L-arginine supplementation been shown to reduce fat mass, but it appears to increase skeletal muscle and brown fat mass and reduce serum concentrations of glucose, triglycerides, free fatty acids, homocysteine, dimethylarginines, and leptin as well [279, 280].”

    From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [279]

  • Rice endosperm protein is high in arginine, a precursor of nitric oxide, which is depleted in the diabetic rat model.

    “Another potential explanation is that a protein such as rice endosperm protein is high in arginine, a precursor of nitric oxide (NO), which is depleted in this rat model [105,106].”
  • Improvement of renal hemodynamics resulting from arginine supplementation could be the direct result of an increase in nitric oxide production.

    “The improvement of renal hemodynamics which results from the supplementation of arginine could be the direct result of an increase in NO production [106].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fu, W. J., Haynes, T. E., Kohli, R., Hu, J., Shi, W., Spencer, T. E., Carroll, R. J., Meininger, C. J., & Wu, G.
Affiliations
  • Texas A&M University (US)
  • Texas A&M Health Science Center (US)
Corresponding author
Wu, Guoyao
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2005-04
Volume
135
Issue
4
Pages
714-721
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2138419214
Cited by
353
References
53
Citations by year
2026: 8 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 17 · 2021: 16 · 2020: 16 · 2019: 20 · 2018: 13 · 2017: 21 · 2016: 19 · 2015: 22 · 2014: 24 · 2013: 22 · 2012: 22
FWCI
12.91
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • National Institutes of Health (5r21hl077401-02, ES09106, R25 CA90301, CA57030)
  • National Heart, Lung, and Blood Institute (R21HL077401-01, ES09106, R21 HL077401)
  • National Cancer Institute (CA 90301, R25 CA90301, R25CA090301, CA 57030)
  • National Institute of Environmental Health Sciences (P30ES009106, P30‐ES09106)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
arginine supplementation, nitric oxide, fat mass, Zucker diabetic fatty rats, type 2 diabetes, obesity, adipose tissue lipolysis, fatty acid oxidation, glucose oxidation, AMPK, PPARγ coactivator-1α, leptin, dimethylarginines, homocysteine, triglycerides, fatty acid binding protein
MeSH terms
Abdomen, Adipose Tissue, Animals, Arginine, Blood Glucose, Diabetes Mellitus, Type 2, Hormones, Lipids, Male, Nitrogen Oxides, Obesity, Rats, Zucker, DNA Primers, Dietary Supplements, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review